Co-administration of Bupropion and Tetracycline
Bupropion and tetracycline can be safely co-administered without dose adjustments, as there are no clinically significant pharmacokinetic or pharmacodynamic interactions between these medications.
Drug Interaction Profile
The FDA-approved prescribing information for bupropion (Wellbutrin) does not list tetracycline antibiotics as contraindicated or requiring special precautions 1. The primary drug interaction concerns with bupropion involve:
- CYP2B6 inhibitors/inducers (affecting bupropion metabolism)
- CYP2D6 substrates (bupropion inhibits this enzyme)
- Drugs that lower seizure threshold
- MAOIs (contraindicated)
- Dopaminergic agents (levodopa, amantadine)
Tetracycline does not fall into any of these categories.
Mechanism Considerations
Bupropion's metabolic pathway: Bupropion is primarily metabolized by CYP2B6 to hydroxybupropion and acts as a CYP2D6 inhibitor 1, 2. Tetracycline antibiotics do not significantly interact with these cytochrome P450 pathways.
Tetracycline's interaction profile: While one guideline mentions tetracyclines in a drug interaction table for amoxicillin (listing "bupropion and other agents lowering seizure threshold") 3, this appears to be a general caution about amoxicillin's potential interaction with seizure-lowering drugs, not a specific tetracycline-bupropion interaction.
Clinical Monitoring
While no dose adjustment is required, standard monitoring for each medication individually remains appropriate:
- For bupropion: Monitor for seizure risk factors (contraindicated in seizure disorders, bulimia, anorexia nervosa, abrupt alcohol/benzodiazepine discontinuation) 1
- For tetracycline: Standard antibiotic monitoring (GI upset, photosensitivity)
Common Pitfall to Avoid
Do not confuse the general seizure risk associated with bupropion (0.48% at doses ≤450 mg/day) 4 with a specific drug-drug interaction. Bupropion's seizure threshold lowering is an intrinsic property, not enhanced by tetracycline co-administration.